Life Sciences
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
The low-cost drug service will be part of Florida-based PharmcoRx's in-pharmacy offerings and will integrate into Expion Health's product suite.
The company will use the funds to grow its drug-discovery pipeline and clinical AI stack.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.
The company will use the funds to expand the reach of its sepsis-focused diagnostic test, IntelliSep.
The Boston-based company will allow employers to customize benefits packages to include adoption, assisted reproductive technologies and surrogacy options.
The Michigan-based cancer care center and medtech giant will create a framework to support scalable solutions that help advance precision medicine in the U.S.
Deirdre Saulet, market vice president for oncology at Carrum Health, discusses the digital platform for self-funded employers' participation in the Cancer Moonshot initiative.
Carebook reports record revenue and the first quarter of positive adjusted EBITDA, while Cue Health sees large net and adjusted EBITDA losses.
Behavioral health platform Eleos Health, virtual chronic care company Vida Health and virtual peer support company Forum also garner investment.